Patents Assigned to INNORA GMBH
-
Patent number: 10806908Abstract: A balloon catheter for treating elongate diseased vessels with a variable diameter, comprising a pre-stretched balloon and a catheter shaft, which forms a wire lumen embodied to guide a guide wire and forms a liquid lumen by which a liquid can be fed to the balloon. The balloon is fastened to a first catheter shaft element at a first, proximal fastening site and fastened to a second catheter shaft element at a second, distal fastening site, wherein the second fastening site is movable along a longitudinal axis of the catheter shaft in relation to the first fastening site. The balloon surrounds a section of the catheter shaft which extends between the first and second fastening sites. Here, the section of the catheter shaft surrounded by the balloon encloses different regions of the catheter shaft with a changing longitudinal extent of the balloon.Type: GrantFiled: April 16, 2014Date of Patent: October 20, 2020Assignee: INNORA GMBHInventors: Uli Hanisch, Ulrich Speck
-
Patent number: 9974888Abstract: The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.Type: GrantFiled: November 3, 2010Date of Patent: May 22, 2018Assignee: INNORA GmbHInventors: Ulrich Speck, Madeleine Caroline Berg
-
Patent number: 9629942Abstract: The present invention is related to a medical device carrying at least on a portion of its surface a Limus drug or Limus drug preparation and butylated hydroxytoluene at a ratio of 3-100% by weight of butylated hydroxytoluene in relation to 100% by weight of the Limus drug.Type: GrantFiled: April 19, 2011Date of Patent: April 25, 2017Assignees: Innora GmbH, Cordin CorporationInventor: Ulrich Speck
-
Patent number: 9539369Abstract: The invention relates to balloon catheters having a polymer-free coating on the balloon surface, said coating comprising at least one limus substance in crystalline form, and to methods for the polymer-free coating of balloon surfaces, in particular balloon catheters, with crystalline limus substances.Type: GrantFiled: September 12, 2014Date of Patent: January 10, 2017Assignee: InnoRa GmbHInventor: Daniel Peters
-
Patent number: 9415140Abstract: The invention relates to an angioplasty catheter having a balloon and a constraining element carrying at least on a portion of its surface a taxane or taxane preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the taxane, wherein a preferred lipophilic antioxidant is propyl gallate. Scoring or cutting balloons as medical devices are excluded.Type: GrantFiled: October 11, 2012Date of Patent: August 16, 2016Assignee: Innora GmbHInventor: Ulrich Speck
-
Publication number: 20160228617Abstract: The invention relates to balloon catheters having a polymer-free coating on the balloon surface, said coating comprising at least one limus substance in crystalline form, and to methods for the polymer-free coating of balloon surfaces, in particular balloon catheters, with crystalline limus substances.Type: ApplicationFiled: September 12, 2014Publication date: August 11, 2016Applicant: InnoRa GmbHInventor: Daniel PETERS
-
Patent number: 9233191Abstract: The present invention is related to a medical device carrying at least on a portion of its surface at least one drug or drug preparation and at least one lipophilic lubricant at a ratio of 0.1-500% by weight of the at least one lubricant in relation to 100% by weight of the drug, wherein the at least one drug is selected of paclitaxel, arsenic trioxide, and lipophilic derivatives of corticoids and selected Limus drugs, and the at least one lipophilic lubricant is a C6-C30-monocarboxylic acid salt.Type: GrantFiled: December 14, 2012Date of Patent: January 12, 2016Assignee: InnoRa GmbHInventors: Madeleine Caroline Berg, Thomas Speck
-
Publication number: 20140322291Abstract: The present invention is related to a medical device carrying at least on a portion of its surface at least one drug or drug preparation and at least one lipophilic lubricant at a ratio of 0.1-500% by weight of the at least one lubricant in relation to 100% by weight of the drug, wherein the at least one drug is selected of paclitaxel, arsenic trioxide, and lipophilic derivatives of corticoids and selected Limus drugs, and the at least one lipophilic lubricant is a C6-C30-monocarboxylic acid salt.Type: ApplicationFiled: December 14, 2012Publication date: October 30, 2014Applicant: INNORA GMBHInventors: Madeleine Caroline Berg, Thomas Speck
-
Publication number: 20130046231Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiaretic acid, resveratrol and propyl gallate.Type: ApplicationFiled: September 27, 2012Publication date: February 21, 2013Applicant: INNORA GMBHInventors: Ulrich Speck, Madeleine Caroline Berg
-
Publication number: 20130046237Abstract: The present invention is related to a medical device carrying at least on a portion of its surface at least one oxidation-insensitive drug or oxidation-insensitive polymer-free drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one antioxidant in relation to 100% by weight of the drug, wherein the at least one oxidation-insensitive drug is selected of taxanes, thalidomide, statins, corticoids and lipophilic derivatives of corticoids, and the at least one lipophilic antioxidant is selected of nordihydroguaiarectic acid, resveratrol and propyl gallate, and wherein scoring or cutting balloons as medical devices are excluded.Type: ApplicationFiled: November 3, 2010Publication date: February 21, 2013Applicant: InnoRa GmbHInventors: Ulrich Speck, Madeleine Caroline Berg
-
Publication number: 20130023817Abstract: The present invention is related to scoring or cutting balloon catheters carrying at least on a portion of their surface at least one drug or drug preparation and at least one lipophilic antioxidant at a ratio of 3-100% by weight of the at least one lipophilic antioxidant in relation to 100% by weight of the drug, wherein a combination of the at least one drug being a limus drug and the at least one lipophilic antioxidant being butylated hydroxytoluene is excluded.Type: ApplicationFiled: September 27, 2012Publication date: January 24, 2013Applicant: INNORA GMBHInventors: Ulrich Speck, Madeleine Caroline Berg